The capnography devices market has seen considerable growth due to a variety of factors.
• The capnography devices market has grown rapidly in recent years. It will grow from $0.74 billion in 2024 to $0.83 billion in 2025, at a compound annual growth rate (CAGR) of 12.3%.
This growth can be attributed to the rising incidence of respiratory diseases, technological advancements, improved patient monitoring, regulatory support, and the aging population.
The capnography devices market is expected to maintain its strong growth trajectory in upcoming years.
• The capnography devices market is expected to grow to $1.31 billion by 2029 at a CAGR of 12.0%.
The growth is driven by more surgical procedures, rising awareness and training programs, regulatory support, and expanding applications. Trends include higher healthcare expenditure, an increased focus on patient safety, expanding home healthcare applications, and increasing use in intensive care units (ICUs).
Gain Insights Into The Capnography Devices Global Market Report 2025 With A Free Sample Report Here:
The rising prevalence of respiratory diseases is expected to drive the capnography devices market. Respiratory diseases, such as asthma and COPD, are increasing due to factors like air pollution, smoking, and aging populations. Capnography devices help monitor respiratory conditions in real-time, aiding in treatment. In June 2024, it was reported that 34% of Australians had chronic respiratory conditions, including 11% with asthma. This growing prevalence of respiratory diseases is boosting the demand for capnography devices.
The capnography devices market covered in this report is segmented –
1) By Component: Original Equipment Manufacturer (OEM) Modules, Other Components
2) By Product: Hand-held, Stand-alone, Multi-parameter
3) By Technology: Mainstream, Sidestream, Microstream
4) By Application: Emergency Medicine, Pain Management, Procedural Sedation, Critical Care, Other Applications
5) By End-use: Hospitals, Ambulatory Care, Other End-Uses
Subsegments:
1) By Original Equipment Manufacturer (OEM) Modules: Sensors, Actuators, Microcontrollers, Power Modules
2) By Other Components: Connectors, Cables, Switches, Enclosures
Companies in the capnography devices market are focusing on advanced pilot studies to assess the effectiveness of devices in clinical settings. Pilot studies evaluate the feasibility and potential impact of these devices. In March 2024, TidalSense initiated a pilot study for its N-Tidal device, designed to diagnose asthma in young children. The device uses capnography technology to measure carbon dioxide levels, offering an alternative to challenging spirometry tests.
Major companies operating in the capnography devices market are:
• Medtronic PLC
• Becton Dickinson and Company (BD)
• GE HealthCare Technologies Inc.
• Medline Industries Inc.
• Philips Healthcare
• Mindray Medical International Limited
• Dräger
• Masimo Corporation
• Nihon Kohden Corporation
• Spacelabs Healthcare
• Vyaire Medical
• ZOLL Medical Corporation
• Edan Instruments Inc.
• Weinmann Emergency Medical Technology GmbH + Co. KG
• Salter Labs Inc.
• MGC Diagnostics Corporation
• Criticare Systems Inc.
• Opto Circuits Limited
• Diamedica Ltd.
• Infinium Medical Inc.
North America was the largest region in the capnography devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capnography devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.